Arginine vasopressin-mediated stimulation of nitric oxide within the rat renal medulla

Hypertension

Volumn 32, Issue 5, 1998, Pages 896-901

  Park, Frank ^a   Zou, Ai Ping ^a   Cowley Jr , Allen W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

L NAME; Nitric oxide; Renal blood flow; Vasopressin

Indexed keywords

ARGIPRESSIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; VASOPRESSIN V2 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; KIDNEY BLOOD FLOW; KIDNEY INTERSTITIUM; KIDNEY MEDULLA; LASER DOPPLER FLOWMETRY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031738947     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.5.896     Document Type: Article

References (35)

1. Cowley AW Jr, Liard JF. Cardiovascular actions of vasopressin. In: Gash DM, Boer GJ, eds. Vasopressin. New York, NY: Plenum Publishing Corp; 1987:389-433.
2. 1 arginine vasopressin agonist results in sustained hypertension. Am J Physiol. 1994;267: H751-H756.
3. Pawloski CM, Eicker NM, Ball LM, Mangiapane ML, Fink GD. Effect of circulating vasopressin on arterial pressure regulation in rats. Am J Physiol. 1989;257:H209-H218.
4. Franchini KG, Cowley AW Jr. Sensitivity of the renal medullary circulation to plasma vasopressin. Am J Physiol. 1996;271:R647-R653.
5. Franchini KG, Mattson DL, Cowley AW Jr. Vasopressin modulation of medullary blood flow and pressure-natriuresis-diuresis in the decerebrated rat. Am J Physiol. 1997;272:R1472-R1479.
6. Franchini KG, Cowley AW Jr. Renal cortical and medullary blood flow responses during water restriction: role of vasopressin. Am J Physiol. 1996;39 (Regulatory Integrative Comp Physiol. 6): R1257-R1264.
7. Franchini KG, Cowley AW Jr. Renal cortical and medullary blood flow responses during water restriction: role of vasopressin. Am J Physiol. 1996;39 (Regulatory Integrative Comp Physiol. 6): R1257-R1264.
8. Cowley AW Jr. Long-term control of arterial blood pressure. Physiol Rev. 1992;72:231-300.
9. 1 vasopressin receptors results in sustained hypertension. Am J Physiol. 1994;267:R1241-R1247.
10. 2 receptors within the renal cortical and medullary circulation. Am J Physiol. 1997;273:R243-R251.
11. Turner MR, Pallone TL. Vasopressin constricts outer medullary descending vasa recta isolated from rat kidneys. Am J Physiol. 1997;272: F147-F151.
12. Cowley AW Jr, Skelton MM, Kurth TM. Long-term vasopressin effects on medullary blood flow and arterial blood pressure. Am J Physiol. In press.
13. Liard JF, Spadone JC. Hemodynamic effects of antagonists of the vasoconstrictor action of vasopressin in conscious dogs. J Cardiovasc Pharmacol. 1984;6:713-719.
14. 2-agonism in dogs. Am J Physiol 1989;256 (Heart Circ Physiol. 25):H1621-H1626.
15. 2-agonism in dogs. Am J Physiol 1989;256 (Heart Circ Physiol. 25):H1621-H1626.
16. 2 receptors. Am J Physiol. 1995;269:R193-R200.
17. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996;32:425-536.
18. Mattson DL, Higgins DJ. Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension. 1996;27:688-692.
19. Mattson DL, Bellehumeur TG. Neural nitric oxide synthase in the renal medulla and blood pressure regulation. Hypertension. 1996;27:688-692.
20. Zou AP, Cowley Jr AW. Nitric oxide in renal cortex and medulla: an in vivo microdialysis study. Hypertension. 1997;29:194-198.
21. Mattson DL, Nakanishi K, Papanek PE, Cowley AW Jr. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol. 1994;266:H1918-H1926.
22. Rudichenko VM, Beierwaltes WH. Arginine vasopressin-induced renal vasodilation mediated by nitric oxide. J Vasc Res. 1995;32:100-105.
23. 2 vasopressin-receptor-mediated renal vasodilation. J Cardiovasc Pharmacol. 1994;23:331-336.
24. 2 receptor in conscious dogs. Am J Physiol. 1993;265: R934-R942.
25. Ikenaga H, Fallet RW, Carmines PK. Basal nitric oxide production curtails arteriolar vasoconstrictor responses to ANGII in the rat kidney. Am J Physiol. 1996;271:F365-F373.
26. Zou AP, Wu F, Cowley AW Jr. Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation. Hypertension. 1998;31:271-276.
27. Manning M, Sawyer WH. Discovery, development, and some uses of vasopressin and oxytocin antagonists. J Lab Clin Med. 1989;114: 617-632.
28. Suzuki S, Takeshita A, Imaizumi T, Kirooka Y, Yoshida M, Ando S, Nakamura M. Biphasic forearm vascular responses to intra-arterial arginine vasopressin. J Clin Invest. 1989;84:427-434.
29. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Hirooka Y, Ando S, Takeshita A. Vasodilator effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels. J Clin Invest. 1993;92:1483-1490.
30. Hirata Y, Hayakawa H, Kakoki M, Tojo A, Suzuki E, Nagata D, Kimura K, Goto A, Kikuchi K, Nagano T, Hirobe M, Omata M. Receptor subtype for vasopressin-induced release of nitric oxide from rat kidney. Hypertension. 1996;29:58-64.
31. 8]vasopressin in the isolated perfused rat kidney. Eur J Pharmacol. 1996;334:325-332.
32. 2 receptor in terminal inner medullary collecting ducts. J Clin Invest. 1995;96:1768-1778.
33. Bachmann S, Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis. 1994;24:112-129.
34. 2+ in rat medullary collecting tubules. Am J Physiol. 1993;265:F35-F45.
35. 2 vasopressin receptor in rat inner medullary collecting duct. Am J Physiol. 1996;270:F623-F633.